Omkar Speciality Chemicals files a patent application

For precursor of latest Hepatitis C Drug

Omkar Speciality Chemicals announced that the Company has filed one more application for the grant of Patent for preparing 4-BROMO-ORTHO-PHENYLENE-DIAMINE, a key precursor for making of the drug namely Ledipasvir. Ledipasvir is a drug for the treatment of Hepatitis C.

Powered by Capital Market - Live News